Source link : https://www.newshealth.biz/health-news/gene-therapy-may-cure-more-rare-diseases-but-drugmakers-have-few-incentives/
Robin Alderman faces an agonizing reality: Gene therapy might cure her son Camden’s rare, inherited immune deficiency. But it’s not available to him. In 2022, London-based Orchard Therapeutics stopped investing in an investigational treatment for the condition, Wiskott-Aldrich syndrome. And there are no gene therapy studies he can join. “We feel like we are the […]
Author : News Health
Publish date : 2024-06-21 15:44:24
Copyright for syndicated content belongs to the linked Source.
Categories